Prostate Cancer: Is AI the Answer to Limit Need of Biopsies?
A retrospective study shows that combining risk markers, MRI evaluation, and AI can more accurately predict prostate cancer risk.
Read MorePosted by Chris Wolski | Aug 6, 2024 | Prostate |
A retrospective study shows that combining risk markers, MRI evaluation, and AI can more accurately predict prostate cancer risk.
Read MorePosted by Chris Wolski | Aug 5, 2024 | Molecular Diagnostic Analyzers |
Indica Labs’ Lung Macrodissect AI, an AI-powered tool designed to enhance slide macrodissection and molecular pathology workflows.
Read MorePosted by Andy Lundin | Jul 26, 2024 | Prostate |
Studies indicate men with BRCA1 and BRCA2 mutations face significant cancer risks, prompting new national screening guidelines.
Read MorePosted by Chris Wolski | Jul 24, 2024 | Disease States |
Research on blood proteins demonstrates the ability of proteins to predict the onset of many diverse diseases.
Read MorePosted by Chris Wolski | Jul 24, 2024 | Analytical Software Systems |
Proscia has launched an updated version of Concentriq AP, enhancing AI-enabled pathology workflows to improve understanding of major cancers.
Read More